Recruiting

Humidity Asthma Interventions for Low Socioeconomic Status Children

The goal of this intervention study is to assess the effectiveness of low-cost humidity and mold reduction interventions in the home for reducing pediatric asthma. The study will have two groups, a treatment group that receives the healthy home interventions during the study and a second control group that will receive these after the study. We will compare pediatric asthma before and three months after the healthy home interventions are performed.

ClinicalTrials.gov IDNCT07453667
PhaseNA
Enrollment80
SponsorCase Western Reserve University
AgeNo minimum reported
SexALL
I'm interested View official listing

Conditions studied

Pediatric Asthma

About this study

The goal of this intervention study is to assess the effectiveness of low-cost humidity and mold reduction interventions in the home for reducing pediatric asthma. The study will have two groups, a treatment group that receives the healthy home interventions during the study and a second control group that will receive these after the study. We will compare pediatric asthma before and three months after the healthy home interventions are performed.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Documented diagnosis of asthma by one child (\< 18 years of age) living within the home * Parent/guardian able to complete informed consent * Residence within the City of Cleveland or immediate suburbs (e.g., East Cleveland, Garfield Heights, Warrensville Heights, Parma, Brook Park, Brooklyn/Old Brooklyn) Exclusion Criteria: * \> 18 years of age * Rental property with landlord unwilling or unable to give consent for remediation

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-28.